96726 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being basic
AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY
#2SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF
#3MITOCHONDRIAL ANTIOXIDANT PEPTIDES
#4ANALOGS THAT TARGET MITOCHONDRIAL DISEASES
#5CATIONICALLY-ENFRAMED HIGH DENSITY AROMATIC PEPTIDES
#6PEPTIDE COMPOSITIONS CAPABLE OF BINDING LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF
#7METHODS FOR REDUCING CD36 EXPRESSION
#8METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#9COMPOSITIONS AND METHODS FOR PURIFYING BIOLOGICAL FLUIDS
#10SULPHONYL BENZENE DERIVATIVES AND METHODS FOR THE PREPARATION OF SULPHONYL BENZENE DERIVATIVES
#11CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2
#12PROTEIN INTERFACES
#13MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION
#14CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#15FUSION PROTEIN FOR TARGETING RECOMBINANT PROTEINS FOR DEGRADATION
#16METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#17POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS
#18AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#19Insect Toxin Delivery Mediated by a Begomovirus Coat Protein
#20PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES
#21AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#22TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#23PSMA-TARGETED NIR DYES AND THEIR USES
#24Antimicrobial Peptides
#25INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE
#26MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES
#27Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
#28Cyanine Dyes
#29METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#30COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
#31TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES
#32TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES
#33METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#34TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE
#35DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS
#36COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#37METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#38Saposin-A derived peptides and uses thereof
#39Methods for the prevention or treatment of heart failure
#40METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#41PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES
#42COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND
#43METHODS FOR REDUCING CD36 EXPRESSION
#44METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#45HOMING PEPTIDE-GUIDED DECORIN CONJUGATES FOR USE IN TREATING EPIDERMOLYSIS BULLOSA
#46METHODS FOR REDUCING OXIDATIVE DAMAGE
#47DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF
#48MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#49MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#50Peptides and compositions for inhibiting hair growth
#51Method and carrier complexes for delivering molecules to cells
#52Fill-finish process for peptide solutions
#53CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#54NRP-1 BINDING INHIBITORY PEPTIDES AND USES THEREOF
#55INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#56METHOD AND COMPOSITION MATTER FOR IMMUNOPROTEASOME-MEDIATED DELIVERY INTO LIVING CELLS
#57PSMA-TARGETED NIR DYES AND THEIR USES
#58Transfection complexes and methods of using the same
#59PEPTIDE INHIBITING ACTIVITY OF ARYL HYDROCARBON RECEPTOR AND COSMETIC COMPOSITION USING SAME
#60Analogs that target mitochondrial diseases
#61COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#62Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient
#63Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
#64AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#65LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#66Protein interfaces
#67Methods for the synthesis of arginine-containing peptides
#68Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
#69MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#70PEPTIDES OF USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
#71METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#72N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#73CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#74CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#75PEPTIDE-COMPRISING ELECTRODE
#76AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#77PEPTIDOMIMETIC INHIBITORS OF THE WDR5-MLL INTERACTION
#78Crystalline bis- and tris-hydrochloride salt of elamipretide
#79Methods for reducing CD36 expression
#80PSMA-targeted NIR dyes and their uses
#81OLIGOPEPTIDE HAVING DENGUE VIRUS REPLICATION INHIBITION FUNCTION AND APPLICATION THEREOF
#82Aromatic-cationic peptides and uses of same
#83Methods for prevention and treatment of acute renal injury
#84METHODS FOR REDUCING OXIDATIVE DAMAGE
#85METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#86CHIRAL PEPTIDES
#87Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
#88LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#89METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#90Salt of phenylpropionamide derivative and preparation method therefor
#91Processes for preparing pharmaceutically relevant peptides
#92AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME
#93Crosslinked hydrogel compositions for regulating states of encapsulated cancer cells
#94Method and carrier complexes for delivering molecules to cells
#95POSITIVE ALLOSTERIC MODULATORS OF GABA A RECEPTOR
#96Recombinant vector carrying cellulose binding domain and method for isolating and purifying protein, using same vector
#97Cyanine dyes
#98Peptide with antidepressant activity and therapeutic effect against Alzheimer's disease
#99Disulfide bond containing compounds and uses thereof
#100Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same
#101Methods for the prevention or treatment of heart failure
#102Saposin-A derived peptides and uses thereof
#103Peptide capable of forming a gel for use in tissue engineering and bioprinting
#104COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#105METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#106MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#107Pharmaceutically relevant aromatic-cationic peptides
#108MALT1 inhibitors and uses thereof
#109Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels
#110METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#111Peptoid affinity ligands
#112AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#113METHODS FOR REDUCING OXIDATIVE DAMAGE
#114Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient
#115CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#116Peptide, fluorescent probe comprising the same, and preparation method thereof
#117COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
#118Recombinant polypeptide production methods
#119METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#120Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer
#121METHODS FOR REDUCING CD36 EXPRESSION
#122Crystalline bis- and tris-hydrochloride salt of elamipretide
#123N-carboxyanhydride-based-scale synthesis of elamipretide
#124Chiral peptides
#125PSMA-targeted NIR dyes and their uses
#126AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#127Peptoid affinity ligands
#128COMPOSITIONS AND METHODS FOR DETERMINING THE PRESENCE OF ACTIVE LEUKOCYTE CELLS USING AN ELECTROCHEMICAL ASSAY
#129THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#130AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#131THERAPEUTIC COMPOUNDS
#132Transfection complexes and methods of using the same
#133METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#134Cyclic peptidomimetics, compositions containing them and their use in the treatment of diseases associated with angiogenesis
#135MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#136N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#137Serpin reactive center loop peptides and methods of use
#138Peptides of use in the preventive and curative treatment of alopecia
#139CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#140Butelase-mediated peptide ligation
#141CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#142Conjugates for treating diseases caused by PSMA expressing cells
#143CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#144CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#145CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#146CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#147MALT1 inhibitors and uses thereof
#148Heme peptide materials for anti-inflammatory regenerative nanobiomedicine
#149METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#150Compositions and methods for inhibition of bacterial infections in human endocervix
#151METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#152METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#153Antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated, and use thereof
#154Peptides and analogs for use in the treatment of oral mucositis
#155Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by Intraceptors
#156Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
#157COMPOSITIONS AND METHODS FOR IDENTIFYING ZIKA ENZYME INHIBITORS
#158Peptide treatment for inflammation and fibrosis
#159Solution phase method for preparing etelcalcetide
#160PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS
#161Inhibitors of growth factor activation enzymes
#162Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof
#163Processes for preparing pharmaceutically relevant peptides
#164SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same
#165NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#166PSMA—targeted NIR dyes and their uses
#167Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#168METHODS FOR REDUCING CD36 EXPRESSION
#169PSMA-targeted NIR dyes and their uses
#170LINEAR PEPTIDE ANTIBIOTICS
#171IGF-I POLY (ETHYLENE GLYCOL) CONJUGATES
#172Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#173AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#174Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same
#175Methods and compounds to suppress viral genome release and packaging
#176Antibacterial agents
#177Cyanine dyes
#178LLP2A-bisphosphonate conjugates for osteoporosis treatment
#179Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
#180Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#181Process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
#182Fluorescent imaging agents
#183Thienopyranones as kinase inhibitors
#184Macrocyclic broad spectrum antibiotics
#185Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#186Method of inhibiting activity of cell surface fibroblast activation protein alpha
#187PSMA-targeted NIR dyes and their uses
#188PSMA-targeted NIR dyes and their uses
#189Tetrapeptide having effect of inhibiting VEGF-induced angiogenesis and use thereof
#190Method and carrier complexes for delivering molecules to cells
#191Neurogenic brain-derived neurotrophic factor peptides
#192AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#193AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#194Surface-binding peptide
#195Conjugates for treating diseases caused by PSMA expressing cells
#196Pharmaceutically relevant aromatic-cationic peptides
#197Pro-angiogenic peptides and peptide conjugates
#198Recombinant polypeptide production methods
#199Methods for reducing oxidative damage
#200Tetrapeptide compound and method for producing same
#201Peptides and analogs for use in the treatment of oral mucositis
#202THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#203AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#204Methods and compositions for the treatment of axonal and neuronal degeneration
#205Short peptides and a method of use as an antioxidant
#206METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#207Compositions and methods of treatment of cancers
#208Modulators for SIRT6 and assays for screening same
#209Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#210Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof
#211LLP2A-bisphosphonate conjugates for osteoporosis treatment
#212Peptide Ligand with Antibody Selectivity and the Application Thereof
#213Tunable control of protein degradation in synthetic and endogenous bacterial systems
#214Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#215Short peptides and a method of use as an antioxidant
#216METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#217Functionalized cyanine dyes (PEG)
#218Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#219Saposin-A derived peptides and uses thereof
#220METHOD FOR SCREENING A NUCLEIC ACID-PROGRAMMED SMALL MOLECULE LIBRARY
#221Scaffold-based polymerase enzyme substrates
#222Conjugates for treating diseases caused by PSMA expressing cells
#223Mucin hypersecretion inhibitors and methods of use
#224Peptides having NF-κB inhibitory activity, or composition comprising same
#225METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#226Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#227COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL ISCHEMIA/REPERFUSION INJURY WITH ANNEXIN A1 SHORT PEPTIDE
#228Prodrugs for selective anticancer therapy
#229Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#230Phospholinked dye analogs with an amino acid linker
#231Fill-finish process for peptide solutions
#232Peptides and use thereof
#233Linear peptide antibiotics
#234DEUTERATED CARFILZOMIB
#235Uses of kappa opioid synthetic peptide amides
#236Salt and protease-resistance of antimicrobial peptide and the manufacture thereof
#237AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#238Substrates and inhibitors of prolyl oligopeptidase and methods of use
#239Peptide tyrosinase inhibitors and uses thereof
#240COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES
#241Peptides for management of lactation
#242Cyanine dyes
#243AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#244Niacin-peptide having skin whitening activity and use for same
#245Bifunctional peptide
#246Modulation of activity of proneurotrophins
#247Cyclin based inhibitors of CDK2 and CDK4
#248Aromatic-cationic peptides and uses of same
#249AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#250Benzylic compound
#251Methods for reducing oxidative damage
#252AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#253Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
#254Cyclin Based Inhibitors of CDK2 and CDK4
#255Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#256Methods for reducing CD36 expression
#257Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#258Lymphatic zip codes in tumors and pre-malignant lesions
#259Macrocyclic broad spectrum antibiotics
#260Peptide analogues with an excellent moisturizing effect and use thereof
#261METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#262Methods for assaying enzyme activities
#263sGCalphal inhibiting compositions
#264Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#265Thienopyranones as kinase inhibitors
#266LLP2A-bisphosphonate conjugates for osteoporosis treatment
#267Neuroprotective and neurorestorative methods and compositions
#268Neurogenic brain-derived neurotrophic factor peptides
#269Modulators for SIRT6 and assays for screening same
#270Methods and compositions related to internalizing RGD peptides
#271Mucin hypersecretion inhibitors and methods of use
#272Methods and compositions for the treatment of axonal and neuronal degeneration
#273AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#274Synthetic peptides useful in the treatment of the skin and use thereof in cosmetic or dermopharmaceutical compositions
#275Cell-protective peptides and uses thereof
#276METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#277Cyclin Based Inhibitors of CDK2 and CDK4
#278Peptide compound useful for inhibiting amyloid plaque formation
#279Methods for preventing or treating mitochondrial permeability transition
#280Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#281Linear peptide antibiotics
#282ANTI-VIRAL AGENT
#283Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications
#284Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#285Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#286Lipid peptide and hydrogel
#287Aziridine mediated native chemical ligation
#288Compositions and Methods for the Intracellular Disruption of VEGF and VEGFR-2 by Intraceptors
#289PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#290High-Affinity Peptide Probes for Tumor Biomarker, GRP-78, and Screening Method Thereof
#291Method and carrier complexes for delivering molecules to cells
#292AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#293C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#294Methods for prevention and treatment of acute renal injury
#295Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
#296COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION
#297AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#298Antimicrobial water treatment membranes and production thereof
#299OPTIMIZED METHOD FOR OBTAINING ACE ACTIVITY INHIBITORY PEPTIDES FROM WHEY, ACE INHIBITORY PEPTIDES AND FOOD COMPRISING THEM
#300SERINE HYDROLASE FORMULATION